Cardios
Cardios is a Brazilian medical device company (founded 1977) that develops and manufactures cardiac diagnostic equipment, including Holter recorders, ambulatory blood pressure monitors, and ECG systems, serving cardiology clinics, hospitals, and analysis centers across Brazil and international markets. Acquired by Cardioline in 2026.
- Company typePrivate
- Founded1977
- HeadquartersParaiso, Brazil
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Cardios does
Cardios is a Brazilian medical device company founded in 1977 and headquartered in São Paulo, specializing in cardiac diagnostic equipment. The company develops and manufactures digital Holter recorders (CardioLight, CardioLight+, CardioSeven, CardioLoop), ambulatory blood pressure monitors (Dyna-MAPA NG, Dyna-MAPA AOP, CardioMapa, ARTERIS AOP), a portable 12-lead ECG (Dynamis ECG), and the HiCardi wearable cardiac telemetry device. Its core technology centers on high-precision ECG acquisition (up to 1,200 samples/second at 12-bit resolution) and proprietary analysis software spanning three tiers (CardioSmart 530/540/550) for varying clinical complexity, from basic clinics to hospital research use.
The business model is hardware-led with a software and services tail. Revenue streams include one-time equipment sales of Holter/MAPA/ECG devices, software licenses, recurring accessories and consumables (cables, straps, cuffs, memory cards) via an online store, warranty and technical support services through an authorized service center network, and training/education courses (24-hour Holter training). Pricing is quote-based (RFQ) with no public disclosure, targeting enterprise healthcare buyers. Distribution combines direct field sales (20 commercial representatives covering all Brazilian regions under a Central de Vendas in São Paulo), regional distributors and authorized service centers, a 100+ partner analysis center network for remote Holter/MAPA reading services via the CardioNet telemedicine platform, and international distribution partnerships. ANVISA-registered products and CE Mark certification (since 2020) support domestic and international market access.
Cardios was acquired by Halma in 2017 and subsequently acquired by Cardioline in April 2026 with backing from healthcare-focused private equity firm ARCHIMED (€9B AUM), creating a global cardiac diagnostic platform with reach across 85+ countries. The company's customer base spans cardiology clinics, hospitals (including Hospital Sírio Libanês and Hospital 9 de Julho), diagnostic centers, remote analysis centers, and veterinary cardiology. With 115,000+ devices deployed and 3 million+ exams processed annually, Cardios is the dominant domestic incumbent in Brazilian Holter and MAPA monitoring, now positioned for international expansion under Cardioline's ownership.
Cardios firmographics
Firmographics- Name
- Cardios
- Legal name
- Cardio Sistemas Comercial Industrial Ltda.
- Website
- https://cardios.com.br
- Company type
- Private
- Founded year
- 1977
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Cardios is a Brazilian medical device company (founded 1977) that develops and manufactures cardiac diagnostic equipment, including Holter recorders, ambulatory blood pressure monitors, and ECG systems, serving cardiology clinics, hospitals, and analysis centers across Brazil and international markets. Acquired by Cardioline in 2026.
- Ownership category
- akta.pro rank
Cardios industry classification
Industry- Product category
- Cardiac Diagnostic Equipment
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cardiology Telemedicine Platforms (HLALAGAB)
- akta.pro secondary industry
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
Keywords
Where Cardios is headquartered
LocationHeadquarters
- HQ city
- Paraiso
- HQ country
- Brazil
- HQ region
- Latin America
Offices2 records
Markets served
Cardios business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Medical Equipment Hardware Sales: Sale of Holter recorders, MAPA monitors, AOP devices, ECG units, and software licenses. Products include CardioLight, CardioLight+, CardioSeven, CardioMapa, Dyna-MAPA NG, Dyna-MAPA AOP, ARTERIS AOP, Dynamis ECG, and CardioSmart software tiers.
- Technical Support and Maintenance Services: Warranty services, remote technical support via TeamViewer, repair and maintenance services, and authorized service center network (Cardioservice, Astton Medical, MHE, Seven-MD, BLB Electronic, Sigeral)
- Training and Education Courses: 24-hour Holter training courses offered in-person and online, scientific congress participation, Hands On sessions at cardiology events
- Accessories and Consumables: Sale of accessories including cables, straps, cuffs, memory cards, carrying cases, and replacement parts through the online accessories store (cardios.srv.br)
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Direct sales quote-based pricing |
Go-to-market motion4 records
Distribution channels6 records
Marketing channels5 records
Cardios product offering
Product offeringCore offering
Cardios develops, manufactures, and commercializes cardiac diagnostic devices and software. Its hardware portfolio includes digital Holter recorders (CardioLight, CardioLight+, CardioSeven, CardioLoop), ambulatory blood pressure monitors (Dyna-MAPA NG, Dyna-MAPA AOP, CardioMapa), pulse wave analysis systems (ARTERIS AOP), and portable 12-lead ECG (Dynamis ECG). Its software ecosystem comprises the CardioSmart analysis suite (tiers 530/540/550), MAPAs blood pressure analysis software, and the CardioNet telemedicine platform for remote exam transmission, server-side management, and DICOM/PACS hospital integration.
Product overview
Cardios is a Brazilian medical device company (founded 1977, headquartered in São Paulo) that develops, manufactures, and commercializes a comprehensive portfolio of cardiac diagnostic solutions including hardware devices and analysis software. The product portfolio spans three main hardware lines: Holter Recorders (CardioLight, CardioLight+, CardioSeven, CardioLoop), Blood Pressure Monitors (Dyna-MAPA NG, Dyna-MAPA AOP, CardioMapa, ARTERIS AOP), and Electrocardiographs (Dynamis ECG), plus a wearable telemetry device (HiCardi). The software ecosystem includes CardioSmart analysis platforms (530/540/550 tiers for increasing complexity), MAPAs blood pressure analysis software, and CardioNet telemedicine infrastructure (Client, Server, DICOM). Products serve human and veterinary (CardioLight Vet) cardiology markets across Brazil and internationally, with 115,000+ devices in market and 3 million annual exams processed. The company was acquired by Cardioline in April 2026.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 115,000+ equipment units deployed in market
- +5 more outcomes
Companies that use Cardios
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles4 records
Cardios technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
Feature10 records
Cardios partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core, flagship, strategic and minor.
- Dong-A STcoreDong-A ST, a Korean pharmaceutical and medical device company, signed a distribution agreement with CARDIOS during Hospitalar 2026 in São Paulo. CARDIOS will provide the HiCardi+ remote patient monitoring solution for distribution in Brazil through a three-party system alongside existing partner CARDIO WEB, leveraging hospital sales infrastructure.
- CARDIO WEBcoreExisting Brazilian cardiac monitoring partner of Cardios for HiCardi+ distribution. CARDIO WEB operates hospital sales infrastructure in Brazil and participates in the three-party distribution system with Dong-A ST for remote patient monitoring solutions.
- CardiolineflagshipCardioline, a globally recognized cardiac diagnostic solutions provider serving 85+ countries, acquired Cardios in April 2026. The acquisition combines Cardioline's international reach and established cardiac technology with Cardios' decades of clinical expertise in Holter and MAPA monitoring. Supported by ARCHIMED private equity. Creates a comprehensive global cardiac diagnostic leadership.
- CNSystemscoreCNSystems partnered with Cardios at the EHRA Congress in Paris to present CardioLight+ and innovative solutions for the European market. This partnership strengthens Cardios' presence in the European cardiac monitoring market through joint exhibition and market development activities.
- ABIMO (Associação Brasileira da Indústria de Dispositivos Médicos)strategicABIMO supports Brazilian medical device exporters like Cardios in prospecting and expanding into international markets. Cardios participated in WHX Nairobi 2025 through ABIMO's export support program, which facilitates market entry and regulatory navigation for Brazilian healthcare companies in Africa and other regions.
- APEX Brasil (Agência Brasileira de Promoção de Exportações e Investimentos)strategicAPEX Brasil promotes Brazilian exports and investments, supporting companies like Cardios in international market expansion. Their assistance helps Cardios reach new markets in Africa, Europe, and Asia through trade facilitation and market intelligence.
- Brazilian Embassy in KenyaminorThe Brazilian Embassy in Kenya facilitated Cardios' participation at WHX Nairobi 2025 by providing local connections, market insights, and regulatory guidance for entering the African healthcare market.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Cardios competitors and assessment
Company assessmentMarket position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
Cardios social profiles
Digital presenceCardios compliance and trust
Trust signalCompliance5 records
Cardios financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cardios leadership team
Management profileNumber of profiles
Profiles1 record
Cardios funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cardios M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cardios
What does Cardios do?
Cardios develops, manufactures, and commercializes cardiac diagnostic devices and software. Its hardware portfolio includes digital Holter recorders (CardioLight, CardioLight+, CardioSeven, CardioLoop), ambulatory blood pressure monitors (Dyna-MAPA NG, Dyna-MAPA AOP, CardioMapa), pulse wave analysis systems (ARTERIS AOP), and portable 12-lead ECG (Dynamis ECG). Its software ecosystem comprises the CardioSmart analysis suite (tiers 530/540/550), MAPAs blood pressure analysis software, and the CardioNet telemedicine platform for remote exam transmission, server-side management, and DICOM/PACS hospital integration.
Is Cardios a public or private company?
Cardios is a private company. It is classified as corporate owned and is currently operating.
When was Cardios founded?
Cardios was founded in 1977. It employs 101 to 250 people.
Where is Cardios based?
Cardios is headquartered in Paraiso, Brazil, in the Latin America region.
How does Cardios make money?
Four revenue lines are on record. Medical Equipment Hardware Sales are the primary driver. The others are technical Support and Maintenance Services, training and Education Courses and accessories and Consumables.
Does Cardios have an API?
No public API is recorded for Cardios.
What industry is Cardios in?
Cardios's product category is Cardiac Diagnostic Equipment. Its primary akta.pro industry code is HLALAGAB, Cardiology Telemedicine Platforms, with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 334510 and its SIC code is 3841.